Search
Share your comments and feedback about ByMySide
Chemotherapy induced anemia
Register for the By My Side™ Cancer Support Network
 
Find out more about chemotherapy and different side effects associated with chemotherapy...
 
   

Prostate Cancer

Prostate cancer is the most commonly diagnosed cancer in U.S. men, with more than 200,000 new diagnoses each year.17 Prostate cancer occurs when the cells in the prostate gland grow out of control. When cells grow out of control, they spread within the prostate and then grow through the capsule that covers the prostate into neighboring organs, or break away and to other parts of the body. Prostate cancer can be relatively harmless or extremely aggressive. Some prostate cancers are slow growing, causing few clinical symptoms. Aggressive cancers spread rapidly to the lymph nodes, other organs and especially, bone.

For many men, the first indication of prostate cancer is a higher than normal PSA (prostate-specific antigen) test. PSA is a protein that is normally produced by the prostate. High levels of PSA in the blood sometimes indicate prostate cancer, although conditions other than cancer can also cause high PSA levels. Men who have an elevated PSA test often undergo additional tests, such as a prostate biopsy, to determine whether cancer is present.

Treatment of prostate cancer will depend on the stage of the disease.

Stage I: The cancer is confined within the prostate and not detectable with a physical examination.

Stage II: The cancer is more advanced than Stage I, but is still confined within the prostate.

Stage III: The cancer extends through the capsule of tissue that surrounds the prostate and may involve the seminal vesicles (nearby glands that help produce semen).

Stage IV: The cancer involves lymph nodes and/or organs or structures outside the prostate other than the seminal vesicles.

American Cancer Society: About Staging

Treatment of prostate cancer varies widely, depending on the stage and characteristics of the cancer and the preferences of your patient. Patients may receive watchful waiting (observation without active treatment until symptoms appear or change), surgery, radiation therapy, hormonal therapy, or chemotherapy. It is important for patients to remember that treatment is determined by the stage and other specific characteristics of the cancer. Patients should speak with their doctor to discuss the individual risks and benefits of each treatment option.

 

Neulasta® (pegfilgrastim) is prescribed to reduce the risk of infection (initially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.

Important product safety information
Ruptured spleen (including fatal cases), serious allergic reactions, and a serious lung problem called acute respiratory distress syndrome have been reported. Call your doctor or seek emergency care right away if you have abdominal or shoulder tip pain, shortness of breath, trouble breathing, a fast rate of breathing, or any allergic reaction. The most common side effect of this injection is mild to moderate bone pain. If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

By My Side™ - Caregiver Resource.   ® 2008 Amgen All rights reserved.
Amgen.com  |  Neulasta.com  |  Neupogen.com  |  Vectibix.com 
Terms of Use  |  Privacy Statement  |  Site Map